checkAd

     113  0 Kommentare Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer - Seite 3

    Contacts:
    Greg Dearborn, Foghorn Therapeutics Inc. (Investors)
    gdearborn@foghorntx.com

    Karin Hellsvik, Foghorn Therapeutics Inc. (Investors & Media)
    khellsvik@foghorntx.com

    Adam Silverstein, ScientPR (Media)
    adam@scientpr.com

    Lesen Sie auch

    Peter Kelleher, LifeSci Advisors (Investors)
    pkelleher@lifesciadvisors.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer - Seite 3 CAMBRIDGE, Mass., April 16, 2024 (GLOBE NEWSWIRE) - Foghorn Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today …